跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 欣蓉
副教授
醫學系內科學科
電子郵件
ssjlee
vghks.gov
tw
h-index
h10-index
h5-index
4324
引文
32
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1053
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
484
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1991 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(183)
類似的個人檔案
(6)
指紋
查看啟用 Susan Shin-Jung Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Taiwan
100%
Southern Taiwan
75%
Cerebrospinal Fluid
39%
Angiostrongylus Cantonensis
39%
Eosinophilic Meningitis
36%
AIDS/HIV
32%
Risk Factors
24%
Mycobacterium Tuberculosis (M. tb)
23%
Clinical Manifestations
21%
Human Immunodeficiency Virus Type 1 (HIV-1)
20%
Latent Tuberculosis Infection
19%
Tuberculosis
19%
Fever
18%
HIV Patients
18%
Medical Center
17%
Kaohsiung
17%
Mycobacterium Tuberculosis Complex
15%
Antimicrobial Resistance
13%
Tuberculin Skin Test
13%
Klebsiella Pneumoniae (K. pneumoniae)
13%
High Prevalence
13%
Clinical Characteristics
13%
Meningitis
12%
Pneumocystis Jirovecii
12%
Intensive Care Unit
12%
Human Immunodeficiency Virus Infection
11%
QuantiFERON-TB Gold In-Tube
11%
Mycobacterium Abscessus
11%
Escherichia Coli
11%
Bloodstream Infection
10%
COVID-19
10%
Infected Patients
10%
Injection Drug Users
10%
Pulmonary Tuberculosis
10%
Syphilis
10%
Urinary Tract Infection
10%
Interferon-gamma Release Assay
10%
Transmitted Drug Resistance
10%
Differential Diagnosis
9%
Dengue Fever
9%
Confidence Interval
9%
Liver Abscess
9%
Antimicrobial
8%
14-3-3 Protein
8%
Highly Active Antiretroviral Therapy (HAART)
8%
Community-acquired
8%
Eating
8%
Liver Cirrhosis
8%
Trimethoprim-sulfamethoxazole (TMP-SMX)
8%
Hepatitis B Virus
8%
Medicine and Dentistry
Human Immunodeficiency Virus
38%
Infection
37%
Disease
25%
Prevalence
22%
Eosinophilic Meningitis
22%
Angiostrongylus cantonensis
17%
Bloodstream Infection
16%
Cerebrospinal Fluid
15%
Klebsiella pneumoniae
15%
Drug Resistance
12%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
12%
Escherichia coli
11%
Liver Abscess
11%
Pathogen
10%
Magnetic Resonance Imaging
10%
Angiostrongyliasis
10%
Pneumocystis Pneumonia
9%
Differential Diagnosis
9%
Mixed Infection
9%
Intensive Care Unit
8%
Mycobacterium Avium Complex
8%
Liver Cirrhosis
8%
Pediatrics
8%
Antiinfective Agent
8%
Japanese Encephalitis
8%
Penicillinase
8%
Lung Tuberculosis
7%
Odds Ratio
7%
Diabetes Mellitus
7%
Retrospective Cohort Study
7%
Eosinophilia
7%
Antibiotic Resistance
7%
Mycobacterium Tuberculosis
7%
Diagnosis
7%
Integrase
7%
Headache
6%
Snail
6%
Mycobacterium Tuberculosis Complex
6%
COVID-19
6%
Pyogenic Liver Abscess
6%
Meningitis
6%
Highly Active Antiretroviral Therapy
6%
Lung Biopsy
6%
Computer Assisted Tomography
6%
Fever of Unknown Origin
6%
Ventilator-Associated Pneumonia
6%
Pontiac Fever
6%
Blood Brain Barrier
6%
Clinician
6%
Pseudomonas aeruginosa
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
48%
HIV
39%
Prevalence
26%
Disease
24%
Eosinophilic Meningitis
21%
Angiostrongyliasis
16%
Tuberculosis
16%
Drug Resistance
16%
Latent Tuberculosis
13%
Klebsiella pneumoniae
11%
Cohort Study
11%
Bloodstream Infection
11%
Adverse Event
11%
Meningitis
9%
Dexamethasone
8%
Human Immunodeficiency Virus 1
8%
Methicillin-Resistant Staphylococcus Aureus
8%
Antiinfective Agent
8%
Mycobacterium Tuberculosis Complex
8%
Tablet
8%
Tuberculin
8%
Bacterial Endocarditis
8%
Matrix-Assisted Laser Desorption/Ionization
8%
Protein 14 3 3
8%
Mycobacterium Tuberculosis
7%
Blood-Brain Barrier
7%
Angiostrongylus cantonensis
7%
Nonnucleoside Reverse Transcriptase Inhibitor
7%
Gamma Interferon
6%
Integrase
6%
Antibiotic Resistance
6%
Antimicrobial Resistance
6%
Lung Tuberculosis
6%
Ciprofloxacin
6%
Carbapenem
5%
Escherichia coli
5%
Hemodialysis
5%
Syndrome
5%
Cellulitis
5%
Aciclovir
5%
Scatter Factor
5%
Herpes Zoster
5%
Cotrimoxazole
5%
Pyrexia Idiopathica
5%
Observational Study
5%
Gelatinase B
5%
Japanese Encephalitis
5%
Legionella
5%
Infectious Agent
5%
Headache
5%
